Related posts

Weekly 52-Week Low (or 52-Week High): BAM-T, IAG-T, ONC-T, CCB-X and More 52-Week Highs and Lows (Oct 02-08)Markets extend advancesTech rebounds, dividends return
Investor Insights

This summary was created by AI, based on 11 opinions in the last 12 months.

The reviews for NWH.UN-T from different experts indicate a mixed sentiment. Some experts see potential in the REIT due to the new CEO's strategic actions, including selling properties and cutting dividends to improve fundamentals. However, concerns about the balance sheet, heavy debt load, and high risk tolerance make some experts cautious about the stock. The healthcare-focused real estate assets and potential benefits from lower interest rates are also noted as positive factors. Overall, the stock seems to have both strengths and challenges, with diverse opinions from experts.

Consensus
Mixed
Valuation
Fair Value
BUY

One of the most attractive REITs on the TSX right now. Coming out of poor fundamental operations where capital allocation was mismanaged. New CEO cut dividend, sold properties. Prepared either way if interest rates fall or rise. Payout ratio will fall closer to 80%. Stock may have fallen recently because that new CEO is retiring next year. Yield is 7.3%, one of the highest out there.

REAL ESTATE
RISKY

Balance sheet's really under pressure, making progress with repairing. Management shakeup, but now the new CEO's leaving in 2025. Lots of heavy work to do. Only for those with high risk tolerance. More compelling opportunities elsewhere.

REAL ESTATE
TOP PICK

It has a 6.2% yield and he doesn't usually put higher yielding stocks into the equity platforms. This one came from the income platform. It fell so fast because it was over-leveraged but has now sold some of its assets. It is building a base and appears to be breaking out so he has bought two of the three legs.                      Buy 0  Hold 5  Sell 0

(Analysts’ price target is $5.85)
REAL ESTATE
DON'T BUY

Cut dividend in 2023. Global scale, so riskier than a traditional Canadian REIT. High occupancy of 96%. She's concerned about pricing pressure. These types of REITs tend to underperform in first stages of a recession. High debt load. Yield is 7%.

REAL ESTATE
TOP PICK

Benefits from lower interest rates and a new CEO. Last year, they cut the dividend (which is safe as its payout ratio falls) and have sold $1.6 billion of assets. Their NAV is $9/share. Their properties serve healthcare, so are stable.

(Analysts’ price target is $5.71)
REAL ESTATE
DON'T BUY

Its sector should be more resilient. Multiple jurisdictions, so multiple currencies and credit risks. Too much debt. Management overhaul. Going through strategic process. Distribution may be challenged. High risk. Better off elsewhere.

REAL ESTATE
DON'T BUY

Strategic review. Management changes. Multiple jurisdictions globally, not very efficient for a Canadian REIT especially with the state of its balance sheet. Lots of headwinds on balance sheet and distribution coverage. High leverage, tight coverage. Good assets, but not lots of options. 

REAL ESTATE
BUY

Large collection of healthcare real estate around the world. Inflation linked leases (good for income). Sticky tenants with doctors and healthcare. Problem is too much floating debt (higher interest rates). Recently replaced management team. Confident on business going forward. Expecting strength going forward. Book value is around $6-$7/share (trading around $4).  

REAL ESTATE
DON'T BUY

It is effectively a REIT. It is down 50% over the past year, a function of interest rate pressure. They have cut their dividend.

REAL ESTATE
PAST TOP PICK
(A Top Pick Dec 14/23, Down 43%)

Healthcare property business not performing as well as anticipating. Floating rate debt very hard on business with rising interest rates. CEO has since resigned. Would recommend holding going forward. 

REAL ESTATE
SELL

Cut dividend. Healthcare properties around the world. Over-levered in a rising interest rate environment. Valuation imploded. Steer clear. Other distressed real estate ideas out there have more catalysts.

REAL ESTATE
DON'T BUY

In flux. Founder/CEO left. Looking at strategic alternatives, possible asset sales. High leverage. A show-me story. Execution risk to sell assets and fix balance sheet in a difficult market.

REAL ESTATE
DON'T BUY

Over-levered. Properties aren't performing as well. Geographic distribution requires them to be experts globally, which is a problem. CEO resigned, change in management. Whole sector's under stress, low quality gets hit harder.

REAL ESTATE
HOLD

Recent cut in dividend. Not expecting any more dividend cuts going forward. Does not own shares at this time. If already own shares, would recommend keeping. 

REAL ESTATE
DON'T BUY

Messy. Cut dividend by 55%. Good lesson on chasing a too-high dividend yield. 97% occupancy, but not enough to keep them out of financial difficulties. $4B of debt, more than 1/3 at floating rates. Giant "For sale" sign on it. Insider selling in January. Facing tax-loss selling if things don't turn around.

REAL ESTATE
Showing 1 to 15 of 120 entries

NorthWest Health Prop Real Est Inv Trust(NWH.UN-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 5

Total Signals / Votes : 9

Stockchase rating for NorthWest Health Prop Real Est Inv Trust is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

NorthWest Health Prop Real Est Inv Trust(NWH.UN-T) Frequently Asked Questions

What is NorthWest Health Prop Real Est Inv Trust stock symbol?

NorthWest Health Prop Real Est Inv Trust is a Canadian stock, trading under the symbol NWH.UN-T on the Toronto Stock Exchange (NWH.UN-CT). It is usually referred to as TSX:NWH.UN or NWH.UN-T

Is NorthWest Health Prop Real Est Inv Trust a buy or a sell?

In the last year, 9 stock analysts published opinions about NWH.UN-T. 4 analysts recommended to BUY the stock. 5 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for NorthWest Health Prop Real Est Inv Trust.

Is NorthWest Health Prop Real Est Inv Trust a good investment or a top pick?

NorthWest Health Prop Real Est Inv Trust was recommended as a Top Pick by on . Read the latest stock experts ratings for NorthWest Health Prop Real Est Inv Trust.

Why is NorthWest Health Prop Real Est Inv Trust stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is NorthWest Health Prop Real Est Inv Trust worth watching?

9 stock analysts on Stockchase covered NorthWest Health Prop Real Est Inv Trust In the last year. It is a trending stock that is worth watching.

What is NorthWest Health Prop Real Est Inv Trust stock price?

On 2024-12-13, NorthWest Health Prop Real Est Inv Trust (NWH.UN-T) stock closed at a price of $4.66.